Case Counts

The Infectious Diseases & Outbreaks Division monitors the incidence and prevalence of communicable, zoonotic, and environmentally-related human diseases. This table summarizes cases reported over the last five years, as well as the cases reported year-to-date this year and last year. 

 

Cases Reported Year-to-Date*

Totals by Year Reported

Condition

2019

2018

% Change

2018

2017

2016

2015

2014

Acute Flaccid Myelitis

0

--

--

--

--

--

--

--

Anthrax

0

0

--

0^

0

0

0

0

Arboviral Diseases (includes West Nile virus, Zika virus, and other Arboviral diseases)

0

4

-100.0%

31

67

60^

10^

23^

Babesiosis

0

0

--

0

1

0

2

1

Botulism

0

0

--

0

0

1

1

0

Brucellosis

0

0

--

1

0

0

2

0

Campylobacteriosis

386

434

-11.1%

783

790

692

589^

255

Cholera

0

0

--

0

0

0

0

0

Coccidioidomycosis

6

--

--

--

--

--

--

--

Cryptosporidiosis

94

83

13.3%

152

189

334

261

147

Cyclosporiasis

0

--

--

--

--

--

--

--

Dengue

0

0

--

3

0

5

3^

3

E. coli, shiga toxin-producing (includes O157: H7)

68

61^

11.5%

129^

31

39

40

41^

Ehrlichiosis/Anaplasmosis

17

11

54.5%

24

17

21

18

19

Giardiasis

76

105

-27.6%

217

191

234

188

182

Hansen's Disease (Leprosy)

0

0

--

0

1

1

1

0

Hantavirus Pulmonary Syndrome

0

--

--

--

--

--

--

--

Hemolytic uremic syndrome (HUS)

2

0

--

3

0

6

3

1

Hepatitis E, acute

0

0

--

0

0

0

0

0

Influenza-associated pediatric mortality

1

2

-50.0%

2

1

0

1

1

Legionellosis

36

32

12.5%

76

66

63

59

62

Leptospirosis

0

1

-100.0%

1

0

0

0

1

Listeriosis

3

5

-40.0%

11

5

8

5

9

Lyme disease

13

20

-35.0%

34

39^

38

25

17

Malaria

2

5

-60.0%

9

8

11

11

14^

Novel Influenza A virus infection

0

0

--

0

0

0

0

0^

Paratyphoid Fever

0^

2^

-100.0%

6^

3

9

0

0

Plague

0

0

--

0

0

0

0

0

Psittacosis

0

0

--

0

0

0

0

0

Q fever

1

1

0.0%

3

0

1

0

2

Rabies, animal

21

26

-19.2%

55

51

77

83

78

Rabies, human

0

0

--

0

0

0

0

0

Salmonellosis

348

429^

-18.9%

1186^

1130^

1276

1151

1165

Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)

0

0

--

0

0

0

0

0

Shigellosis

130

144

-9.7%

320

247^

239

680

516

Spotted Fever Rickettsiosis

205

339

-39.5%

676

671

453

288

220

Toxic Shock Syndrome (non-streptococcal)

0

--

--

--

--

--

--

--

Trichinellosis (Trichinosis)

0

0

--

0

0

0

0

0^

Tularemia

3

0

--

0

1^

1

0

0

Typhoid fever

0^

0

--

1

1

0

0

2

VISA (Staphylococcus aureus, vancomycin-intermediate)

0

1

-100.0%

1

4

3

2

2

VRSA (Staphylococcus aureus, vancomycin-resistant)

0

0

--

0

0

0

0

0

Vibriosis (non-Cholera)

17

16

6.3%

38

26^

31

19

20

Yellow Fever

0^

0

--

0

0

0

0

0

Other Investigations

0

0

--

0

0

0

0

27

Total

1429

1721

-17.0%

3925

2097

3543

2840

2730

NOTE: Counts include finalized investigations among Alabama residents as of July 17, 2019. The Other investigations category includes a variety of conditions or events that have been investigated, but are not reportable in Alabama or do not fall into any other category (e.g., Histoplasmosis, Streptococcal toxic-shock syndrome, Yersiniosis, etc.). To see case counts for conditions investigated by other divisions, please see the following websites: Tuberculosis, Immunizations, Sexually Transmitted Diseases, and HIV/AIDS.

*Through MMWR Week 28 (week ending July 13, 2019), as compared to the same time period in the previous calendar year.

^The case definition was updated this year for this condition.





Page last updated: July 17, 2019